T. Rowe Price Associates’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-813
| Closed | -$63K | – | 2908 |
|
|
2023
Q2 | $63K | Sell |
813
-93
| -10% | -$7.21K | ﹤0.01% | 2768 |
|
|
2023
Q1 | $86K | Buy |
906
+316
| +54% | +$30K | ﹤0.01% | 2712 |
|
|
2022
Q4 | $57K | Hold |
590
| – | – | ﹤0.01% | 2794 |
|
|
2022
Q3 | $153K | Sell |
590
-73
| -11% | -$18.9K | ﹤0.01% | 2621 |
|
|
2022
Q2 | $123K | Sell |
663
-216
| -25% | -$40.1K | ﹤0.01% | 2710 |
|
|
2022
Q1 | $86K | Buy |
879
+119
| +16% | +$11.6K | ﹤0.01% | 2863 |
|
|
2021
Q4 | $124K | Sell |
760
-776
| -51% | -$127K | ﹤0.01% | 2842 |
|
|
2021
Q3 | $419K | Buy |
1,536
+850
| +124% | +$232K | ﹤0.01% | 2449 |
|
|
2021
Q2 | $272K | Buy |
686
+55
| +9% | +$21.8K | ﹤0.01% | 2618 |
|
|
2021
Q1 | $341K | Sell |
631
-89
| -12% | -$48.1K | ﹤0.01% | 2516 |
|
|
2020
Q4 | $272K | Sell |
720
-5
| -0.7% | -$1.89K | ﹤0.01% | 2457 |
|
|
2020
Q3 | $274K | Hold |
725
| – | – | ﹤0.01% | 2321 |
|
|
2020
Q2 | $357K | Buy |
725
+15
| +2% | +$7.39K | ﹤0.01% | 2187 |
|
|
2020
Q1 | $261K | Buy |
710
+27
| +4% | +$9.93K | ﹤0.01% | 2238 |
|
|
2019
Q4 | $484K | Buy |
683
+60
| +10% | +$42.5K | ﹤0.01% | 2155 |
|
|
2019
Q3 | $400K | Buy |
623
+5
| +0.8% | +$3.21K | ﹤0.01% | 2175 |
|
|
2019
Q2 | $540K | Buy |
618
+5
| +0.8% | +$4.37K | ﹤0.01% | 2077 |
|
|
2019
Q1 | $354K | Buy |
613
+3
| +0.5% | +$1.73K | ﹤0.01% | 2237 |
|
|
2018
Q4 | $171K | Sell |
610
-100
| -14% | -$28K | ﹤0.01% | 2424 |
|
|
2018
Q3 | $341K | Buy |
710
+194
| +38% | +$93.2K | ﹤0.01% | 2297 |
|
|
2018
Q2 | $234K | Buy |
516
+6
| +1% | +$2.72K | ﹤0.01% | 2406 |
|
|
2018
Q1 | $300K | Buy |
510
+140
| +38% | +$82.4K | ﹤0.01% | 2281 |
|
|
2017
Q4 | $230K | Sell |
370
-78
| -17% | -$48.5K | ﹤0.01% | 2359 |
|
|
2017
Q3 | $412K | Buy |
448
+104
| +30% | +$95.6K | ﹤0.01% | 2146 |
|
|
2017
Q2 | $321K | Sell |
344
-91
| -21% | -$84.9K | ﹤0.01% | 2221 |
|
|
2017
Q1 | $414K | Hold |
435
| – | – | ﹤0.01% | 2134 |
|
|
2016
Q4 | $349K | Hold |
435
| – | – | ﹤0.01% | 2194 |
|
|
2016
Q3 | $367K | Hold |
435
| – | – | ﹤0.01% | 2136 |
|
|
2016
Q2 | $358K | Buy |
435
+86
| +25% | +$70.8K | ﹤0.01% | 2098 |
|
|
2016
Q1 | $388K | Hold |
349
| – | – | ﹤0.01% | 2069 |
|
|
2015
Q4 | $435K | Sell |
349
-268
| -43% | -$334K | ﹤0.01% | 2017 |
|
|
2015
Q3 | $833K | Buy |
617
+72
| +13% | +$97.2K | ﹤0.01% | 1760 |
|
|
2015
Q2 | $982K | Buy |
545
+210
| +63% | +$378K | ﹤0.01% | 1751 |
|
|
2015
Q1 | $541K | Sell |
335
-86
| -20% | -$139K | ﹤0.01% | 1944 |
|
|
2014
Q4 | $320K | Hold |
421
| – | – | ﹤0.01% | 2145 |
|
|
2014
Q3 | $167K | Buy |
421
+134
| +47% | +$53.2K | ﹤0.01% | 2385 |
|
|
2014
Q2 | $173K | Hold |
287
| – | – | ﹤0.01% | 2393 |
|
|
2014
Q1 | $197K | Hold |
287
| – | – | ﹤0.01% | 2329 |
|
|
2013
Q4 | $187K | Buy |
+287
| New | +$187K | ﹤0.01% | 2328 |
|